Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
交易所：HKG。行业板块：Healthcare。细分行业：Drug Manufacturers - Specialty & Generic。最新股价：HK$59.9。本页提供 Jiangsu Hengrui Pharmaceuticals Co.,Ltd 的 DCF 现金流折现估值、相对估值历史分位、多维财务评分与 AI 辅助分析。
Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.